Release Date: 27/01/16 09:17 Summary: December 2015 Quarterly Activities Report Price Sensitive: Yes Download Document 1.56MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%